From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
United Kingdom
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Vietnam
From €1346EUR$1,500USD£1,158GBP
- Report
- November 2023
- 102 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
- Report
- March 2023
- 322 Pages
Global
From €2242EUR$2,499USD£1,930GBP
€3203EUR$3,570USD£2,757GBP
Ethambutol is a drug used to treat respiratory diseases such as tuberculosis and Mycobacterium avium complex (MAC). It is an antibiotic that works by inhibiting the growth of bacteria in the lungs. It is usually prescribed in combination with other drugs to treat tuberculosis. Ethambutol is also used to prevent the spread of tuberculosis in people who have been exposed to the disease.
Ethambutol is available in both oral and injectable forms. It is usually taken once or twice daily, depending on the severity of the infection. Common side effects of ethambutol include nausea, vomiting, loss of appetite, and vision changes.
The ethambutol market is a growing segment of the respiratory drugs market. It is used to treat a variety of respiratory diseases, including tuberculosis and MAC. The increasing prevalence of tuberculosis and other respiratory diseases is driving the demand for ethambutol.
Some companies in the ethambutol market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more